| phospholipid transfer to membrane | GO:0006649 | 2 | 0.970 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.789 | |
| negative regulation of cellular amide metabolic process | GO:0034249 | 4 | 0.778 | |
| reverse cholesterol transport | GO:0043691 | 6 | 0.777 | |
| positive regulation of reverse cholesterol transport | GO:1903064 | 1 | 0.714 | |
| organophosphate ester transport | GO:0015748 | 28 | 0.660 | Human |
| positive regulation of sterol transport | GO:0032373 | 9 | 0.610 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.577 | |
| regulation of phospholipid transport | GO:2001138 | 4 | 0.563 | |
| positive regulation of beta amyloid clearance | GO:1900223 | 1 | 0.558 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.535 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.495 | |
| regulation of beta amyloid clearance | GO:1900221 | 1 | 0.492 | |
| phospholipid transport | GO:0015914 | 21 | 0.469 | Human |
| intracellular lipid transport | GO:0032365 | 3 | 0.454 | Human |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.427 | Human |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.421 | |
| cdc42 protein signal transduction | GO:0032488 | 0 | 0.414 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.386 | |
| regulation of phospholipid efflux | GO:1902994 | 2 | 0.384 | |
| lytic vacuole organization | GO:0080171 | 21 | 0.373 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.368 | Human |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.365 | Human |
| phospholipid efflux | GO:0033700 | 3 | 0.351 | Human |
| intracellular cholesterol transport | GO:0032367 | 3 | 0.344 | Human |
| ras protein signal transduction | GO:0007265 | 77 | 0.324 | |
| regulation of ion transport | GO:0043269 | 215 | 0.305 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.298 | |
| sensory perception | GO:0007600 | 245 | 0.297 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.295 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.284 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.282 | |
| positive regulation of cholesterol transport | GO:0032376 | 9 | 0.277 | |
| negative regulation of beta amyloid formation | GO:1902430 | 4 | 0.273 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.263 | Human |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.260 | Human |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.259 | Human |
| amine metabolic process | GO:0009308 | 45 | 0.257 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.256 | Human |
| plasma lipoprotein particle organization | GO:0071827 | 11 | 0.249 | |
| transmembrane transport | GO:0055085 | 412 | 0.246 | Human |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.244 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.241 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.229 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.227 | Human |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.227 | Human |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.220 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.220 | Human |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.219 | |
| positive regulation of phospholipid transport | GO:2001140 | 4 | 0.219 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.218 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.207 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.203 | |
| protein lipidation | GO:0006497 | 28 | 0.201 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.199 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.197 | Human |
| organic anion transport | GO:0015711 | 137 | 0.196 | Human |
| cholesterol efflux | GO:0033344 | 24 | 0.190 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.187 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.186 | |
| response to low density lipoprotein particle | GO:0055098 | 2 | 0.185 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.184 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.183 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.183 | Human |
| nucleoside metabolic process | GO:0009116 | 246 | 0.183 | Human |
| lysosome organization | GO:0007040 | 21 | 0.183 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.182 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.181 | Human |
| cholesterol transport | GO:0030301 | 38 | 0.180 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.180 | Human |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.178 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.178 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.177 | Human |
| negative regulation of cell activation | GO:0050866 | 111 | 0.169 | |
| lipid homeostasis | GO:0055088 | 63 | 0.168 | Human |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.167 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.167 | Human |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.166 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.166 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.164 | Human |
| regulation of t cell activation | GO:0050863 | 170 | 0.164 | |
| regulation of reverse cholesterol transport | GO:1903062 | 1 | 0.164 | |
| anion transport | GO:0006820 | 177 | 0.163 | Human |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.161 | Human |
| activation of immune response | GO:0002253 | 138 | 0.160 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.159 | Human |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.159 | |
| cellular response to lipid | GO:0071396 | 145 | 0.157 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.155 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.155 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.153 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.150 | Human |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.149 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.148 | |
| phospholipid translocation | GO:0045332 | 9 | 0.144 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.144 | |
| high density lipoprotein particle assembly | GO:0034380 | 3 | 0.137 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.137 | |
| endocytosis | GO:0006897 | 168 | 0.135 | |
| secretory granule organization | GO:0033363 | 20 | 0.134 | |
| membrane organization | GO:0061024 | 245 | 0.134 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.134 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.133 | Human |
| regulation of amyloid precursor protein catabolic process | GO:1902991 | 8 | 0.133 | |
| positive regulation of phagocytosis engulfment | GO:0060100 | 3 | 0.131 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.131 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.130 | |
| intracellular sterol transport | GO:0032366 | 3 | 0.130 | Human |
| cation transmembrane transport | GO:0098655 | 266 | 0.125 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.125 | |
| muscle system process | GO:0003012 | 141 | 0.122 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.122 | |
| positive regulation of lipid transport | GO:0032370 | 22 | 0.122 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.121 | Human |
| visual perception | GO:0007601 | 52 | 0.121 | |
| skin development | GO:0043588 | 220 | 0.119 | |
| regulation of cholesterol transport | GO:0032374 | 17 | 0.118 | |
| regulation of amyloid precursor protein biosynthetic process | GO:0042984 | 3 | 0.118 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.115 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.115 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.114 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.114 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.111 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.110 | |
| beta amyloid clearance | GO:0097242 | 2 | 0.109 | |
| peptide metabolic process | GO:0006518 | 46 | 0.108 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.108 | Human |
| cholesterol metabolic process | GO:0008203 | 56 | 0.108 | |
| sterol transport | GO:0015918 | 38 | 0.108 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.107 | Human |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.106 | |
| epidermis development | GO:0008544 | 187 | 0.106 | |
| cell adhesion | GO:0007155 | 329 | 0.105 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.104 | Human |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.103 | Human |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.103 | Human |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.103 | |
| vacuole organization | GO:0007033 | 38 | 0.103 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.102 | Human |
| regulation of endocytosis | GO:0030100 | 69 | 0.101 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.101 | |
| positive regulation of apoptotic cell clearance | GO:2000427 | 3 | 0.099 | |
| leukocyte migration | GO:0050900 | 124 | 0.098 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.098 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.097 | Human |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.097 | |
| sterol homeostasis | GO:0055092 | 45 | 0.097 | Human |
| amyloid precursor protein biosynthetic process | GO:0042983 | 3 | 0.096 | |
| response to radiation | GO:0009314 | 165 | 0.095 | |
| cell chemotaxis | GO:0060326 | 81 | 0.095 | |
| cognition | GO:0050890 | 149 | 0.093 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.092 | |
| peptide secretion | GO:0002790 | 114 | 0.092 | |
| tissue homeostasis | GO:0001894 | 115 | 0.091 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.091 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.090 | Human |
| regulation of transferase activity | GO:0051338 | 263 | 0.089 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.087 | |
| camp metabolic process | GO:0046058 | 40 | 0.087 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.087 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.086 | |
| learning or memory | GO:0007611 | 148 | 0.086 | |
| sterol metabolic process | GO:0016125 | 58 | 0.085 | |
| regulation of sterol transport | GO:0032371 | 17 | 0.084 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.084 | Human |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.083 | Human |
| macromolecule catabolic process | GO:0009057 | 281 | 0.083 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.083 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.082 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.081 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.081 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.081 | |
| negative regulation of glycoprotein metabolic process | GO:1903019 | 3 | 0.081 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.081 | Human |
| protein secretion | GO:0009306 | 111 | 0.080 | |
| keratinocyte differentiation | GO:0030216 | 48 | 0.079 | |
| regulation of anion transport | GO:0044070 | 27 | 0.079 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.079 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.078 | |
| regulation of cholesterol efflux | GO:0010874 | 13 | 0.076 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.076 | Human |
| regulation of membrane lipid distribution | GO:0097035 | 16 | 0.076 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.075 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.073 | Human |
| camp biosynthetic process | GO:0006171 | 31 | 0.073 | |
| photoreceptor cell maintenance | GO:0045494 | 19 | 0.072 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.072 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.072 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.072 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.070 | |
| lipid translocation | GO:0034204 | 9 | 0.069 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.069 | |
| memory | GO:0007613 | 58 | 0.068 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.067 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.067 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.065 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.065 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.064 | |
| immune effector process | GO:0002252 | 321 | 0.064 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.064 | |
| t cell activation | GO:0042110 | 289 | 0.064 | |
| regulation of cell migration | GO:0030334 | 219 | 0.063 | |
| lipid modification | GO:0030258 | 65 | 0.063 | |
| cytokine secretion | GO:0050663 | 72 | 0.063 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.062 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.062 | |
| chemical homeostasis within a tissue | GO:0048875 | 9 | 0.062 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.062 | |
| vesicle organization | GO:0016050 | 60 | 0.062 | |
| positive regulation of purine nucleotide biosynthetic process | GO:1900373 | 26 | 0.061 | |
| protein lipid complex subunit organization | GO:0071825 | 12 | 0.061 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.061 | |
| regulation of beta amyloid formation | GO:1902003 | 8 | 0.061 | |
| positive regulation of protein localization to cell surface | GO:2000010 | 2 | 0.061 | |
| cytokine production | GO:0001816 | 319 | 0.060 | |
| positive regulation of camp metabolic process | GO:0030816 | 19 | 0.060 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.059 | Human |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.059 | |
| granulocyte chemotaxis | GO:0071621 | 39 | 0.058 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.058 | |
| mapk cascade | GO:0000165 | 281 | 0.058 | |
| adaptive immune response | GO:0002250 | 155 | 0.057 | |
| chemotaxis | GO:0006935 | 247 | 0.057 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.057 | |
| lipid catabolic process | GO:0016042 | 69 | 0.057 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.056 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.056 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.056 | |
| positive regulation of engulfment of apoptotic cell | GO:1901076 | 1 | 0.055 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.055 | |
| positive regulation of cholesterol efflux | GO:0010875 | 9 | 0.055 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.054 | |
| positive regulation of phospholipid efflux | GO:1902995 | 2 | 0.054 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.054 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.054 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.053 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.053 | |
| regulation of phagocytosis engulfment | GO:0060099 | 5 | 0.053 | |
| germ cell development | GO:0007281 | 185 | 0.053 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.052 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.052 | |
| membrane invagination | GO:0010324 | 17 | 0.052 | |
| amyloid precursor protein catabolic process | GO:0042987 | 10 | 0.051 | Human |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.051 | |
| phagocytosis | GO:0006909 | 66 | 0.051 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.051 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.050 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.050 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.050 | |
| positive regulation of cyclic nucleotide metabolic process | GO:0030801 | 24 | 0.050 | |
| retina homeostasis | GO:0001895 | 23 | 0.049 | |
| establishment of skin barrier | GO:0061436 | 14 | 0.049 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.049 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.049 | |
| lung development | GO:0030324 | 164 | 0.049 | |
| regulation of camp biosynthetic process | GO:0030817 | 25 | 0.049 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.049 | Human |
| beta amyloid metabolic process | GO:0050435 | 14 | 0.048 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.048 | |
| granulocyte migration | GO:0097530 | 43 | 0.048 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.047 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.047 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.047 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.047 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.047 | Human |
| beta amyloid formation | GO:0034205 | 9 | 0.047 | |
| neuron projection guidance | GO:0097485 | 141 | 0.046 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.046 | |
| response to retinoic acid | GO:0032526 | 56 | 0.046 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.046 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.046 | Human |
| wound healing | GO:0042060 | 157 | 0.046 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.045 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.045 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.045 | |
| atp metabolic process | GO:0046034 | 75 | 0.045 | Human |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.045 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.045 | |
| regulation of cdc42 protein signal transduction | GO:0032489 | 5 | 0.044 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.044 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.044 | |
| cation transport | GO:0006812 | 399 | 0.044 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.044 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.043 | |
| positive regulation of growth | GO:0045927 | 104 | 0.043 | |
| cellular response to retinoic acid | GO:0071300 | 25 | 0.043 | |
| response to acid chemical | GO:0001101 | 111 | 0.043 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.043 | |
| cation homeostasis | GO:0055080 | 212 | 0.043 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.042 | |
| neuronal action potential | GO:0019228 | 54 | 0.042 | |
| activation of mapk activity | GO:0000187 | 59 | 0.042 | |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.042 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.042 | |
| regulation of cell activation | GO:0050865 | 289 | 0.042 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.041 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.041 | |
| locomotory behavior | GO:0007626 | 195 | 0.041 | |
| plasma lipoprotein particle assembly | GO:0034377 | 6 | 0.041 | |
| peptide transport | GO:0015833 | 133 | 0.041 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.041 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.041 | |
| regulation of cell motility | GO:2000145 | 236 | 0.041 | |
| atp catabolic process | GO:0006200 | 55 | 0.041 | Human |
| protein localization to organelle | GO:0033365 | 185 | 0.041 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.040 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.040 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.040 | |
| spermatid development | GO:0007286 | 108 | 0.040 | |
| tissue remodeling | GO:0048771 | 102 | 0.040 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.039 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.039 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.039 | |
| dendrite development | GO:0016358 | 115 | 0.039 | |
| regulation of cyclic nucleotide biosynthetic process | GO:0030802 | 31 | 0.038 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.038 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.038 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.037 | |
| positive regulation of camp biosynthetic process | GO:0030819 | 19 | 0.037 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.037 | |
| negative regulation of nik nf kappab signaling | GO:1901223 | 2 | 0.037 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.036 | |
| steroid metabolic process | GO:0008202 | 119 | 0.036 | |
| response to light stimulus | GO:0009416 | 135 | 0.035 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.035 | |
| protein ubiquitination | GO:0016567 | 171 | 0.035 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.035 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.035 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.035 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.035 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.035 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.034 | Human |
| formation of radial glial scaffolds | GO:0021943 | 4 | 0.034 | |
| negative regulation of glycoprotein biosynthetic process | GO:0010561 | 3 | 0.034 | |
| regulation of water loss via skin | GO:0033561 | 16 | 0.034 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.034 | |
| b cell activation | GO:0042113 | 161 | 0.034 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.034 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.034 | |
| keratinization | GO:0031424 | 9 | 0.034 | |
| calcium ion transport | GO:0006816 | 159 | 0.033 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.033 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.033 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.033 | |
| defense response to other organism | GO:0098542 | 197 | 0.033 | |
| protein glycosylation | GO:0006486 | 55 | 0.033 | |
| angiogenesis | GO:0001525 | 201 | 0.033 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.032 | |
| inflammatory response | GO:0006954 | 244 | 0.032 | |
| organic acid transport | GO:0015849 | 101 | 0.032 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.032 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.032 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.032 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.032 | |
| axonogenesis | GO:0007409 | 274 | 0.032 | |
| detection of stimulus | GO:0051606 | 84 | 0.032 | |
| amide transport | GO:0042886 | 138 | 0.032 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.032 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.032 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.032 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.032 | |
| negative regulation of sterol transport | GO:0032372 | 4 | 0.031 | |
| regulation of coagulation | GO:0050818 | 31 | 0.031 | |
| endomembrane system organization | GO:0010256 | 147 | 0.031 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.031 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.031 | |
| regulation of defense response | GO:0031347 | 233 | 0.031 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.031 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.030 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.030 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.030 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.030 | |
| dna metabolic process | GO:0006259 | 303 | 0.030 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.030 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.030 | |
| maintenance of location | GO:0051235 | 89 | 0.030 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.030 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.030 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.029 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.029 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.029 | Human |
| placenta development | GO:0001890 | 140 | 0.029 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.029 | |
| lipid localization | GO:0010876 | 126 | 0.029 | |
| skeletal system development | GO:0001501 | 356 | 0.029 | |
| cell maturation | GO:0048469 | 127 | 0.029 | |
| adult behavior | GO:0030534 | 135 | 0.029 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.028 | |
| spermatogenesis | GO:0007283 | 284 | 0.028 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.028 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.028 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.028 | |
| male gamete generation | GO:0048232 | 285 | 0.028 | |
| protein oligomerization | GO:0051259 | 67 | 0.028 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.028 | |
| dephosphorylation | GO:0016311 | 129 | 0.028 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.027 | |
| lung alveolus development | GO:0048286 | 45 | 0.027 | |
| epidermal growth factor receptor signaling pathway via i kappab kinase nf kappab cascade | GO:0038168 | 1 | 0.027 | |
| methylation | GO:0032259 | 134 | 0.027 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.027 | |
| neuron death | GO:0070997 | 154 | 0.027 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.027 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.027 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.026 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.026 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.026 | |
| coagulation | GO:0050817 | 78 | 0.026 | |
| response to lipoprotein particle | GO:0055094 | 5 | 0.026 | |
| macromolecule methylation | GO:0043414 | 120 | 0.026 | |
| blood coagulation | GO:0007596 | 76 | 0.026 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.026 | |
| response to nutrient levels | GO:0031667 | 109 | 0.026 | |
| sensory perception of chemical stimulus | GO:0007606 | 51 | 0.026 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.026 | |
| forebrain development | GO:0030900 | 302 | 0.026 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.026 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.026 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.026 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.025 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.025 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.025 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.025 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.025 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.025 | |
| cellular homeostasis | GO:0019725 | 240 | 0.025 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.025 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.025 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.025 | Human |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.025 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.025 | |
| activation of innate immune response | GO:0002218 | 56 | 0.025 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.025 | |
| histone modification | GO:0016570 | 159 | 0.025 | |
| gliogenesis | GO:0042063 | 141 | 0.025 | |
| cgmp metabolic process | GO:0046068 | 20 | 0.024 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.024 | |
| glial cell differentiation | GO:0010001 | 131 | 0.024 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.024 | |
| response to drug | GO:0042493 | 75 | 0.024 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.024 | |
| lipid storage | GO:0019915 | 36 | 0.024 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.024 | |
| chromatin modification | GO:0016568 | 187 | 0.024 | |
| positive thymic t cell selection | GO:0045059 | 13 | 0.024 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.024 | Human |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.024 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.024 | Human |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.024 | |
| positive t cell selection | GO:0043368 | 23 | 0.024 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.024 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.024 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.023 | |
| dendritic spine maintenance | GO:0097062 | 4 | 0.023 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.023 | |
| regulation of autophagy | GO:0010506 | 30 | 0.023 | |
| connective tissue development | GO:0061448 | 179 | 0.023 | |
| glycosylation | GO:0070085 | 62 | 0.023 | |
| somatic cell dna recombination | GO:0016444 | 51 | 0.023 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.023 | |
| anion homeostasis | GO:0055081 | 16 | 0.023 | Human |
| innate immune response in mucosa | GO:0002227 | 3 | 0.023 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.023 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.023 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.023 | |
| multicellular organismal water homeostasis | GO:0050891 | 23 | 0.023 | |
| fertilization | GO:0009566 | 127 | 0.023 | |
| protein methylation | GO:0006479 | 81 | 0.023 | |
| gland development | GO:0048732 | 330 | 0.023 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.023 | Human |
| heart process | GO:0003015 | 94 | 0.023 | |
| lipid transport | GO:0006869 | 98 | 0.023 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.022 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.022 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.022 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.022 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.022 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.022 | |
